Skip to search formSkip to main contentSkip to account menu

pirazolac

Known as: 4-(4-chlorophenyl)-1-(4-fluorophenyl)pyrazole-3-acetic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
SummaryThe absorption, disposition, biotransformation and excretion of the nonsteroidal anti-inflammatory drug pirazolac were… 
2004
2004
The concentration-time course of pirazolac in plasma and its urinary excretion were investigated in 6 young volunteers (3 males… 
2004
2004
SummaryFollowing a washout period of 7 days, twenty-one patients suffering from rheumatoid arthritis and 3 from osteo-arthritis… 
2003
2003
The compounds 1,3,5-triphenyl-4,5-dihydro pyrazole, 1,3-diphenyl-5(p-methoxy phenyl)-4,5-dihydro pyrazole and 1,3-diphenyl-5(p… 
1990
1990
A 12-week trial was carried out to compare the efficacy of pirazolac (300-600 mg b.i.d.) with that of indomethacin (25-50 mg t.i… 
1990
1990
  • U. Täuber
  • Drugs under experimental and clinical research
  • 1990
  • Corpus ID: 44969991
Pirazolac (PAA) is a new non-steroidal anti-inflammatory drug (NSAID) belonging to the subgroup of heterocyclic acetic acids. PAA… 
1990
1990
Neutrophils from 20 medication-free rheumatoid arthritis patients were chemotactically hyporesponsive to 2 x 10(-8) M formyl… 
1987
1987
Six patients suffering from rheumatoid arthritis with massive knee joint effusions were treated with single daily doses of 600 mg… 
1985
1985
Twenty-four patients with classical or definite rheumatoid arthritis participated in a 4-week double-blind crossover study to… 
1985
1985
A study was carried out in 10 healthy subjects to compare the faecal blood loss caused by pirazolac, a new non-steroidal anti…